

















Technology
Technology
Revealing causal biology at a genome-wide scale

























Enhanced's proprietary 3D multi- omics platform decodes the function of the entire human genome to identify novel targets
Rapidly identifying new, high-confidence, first-in-class therapeutic targets for common diseases, 10x faster than other methods.
The platform is generating unparalleled genetically validated therapeutic targets, in the most relevant cell types, across the entire human genome to more than double the probability of drug development success.
10x
10x
10x
faster at identifying therapeutic targets
2x
2x
2x
increase in drug development success based on genetic validation


An integrated approach to causal biology
The platform is generating unparalleled genetic validation of disease-relevant targets, in the most relevant cell types, across the entire human genome to more than double the probability of drug development success.

3D Genomics
Our proprietary platform analyzes genome folding at high resolution, linking gene enhancers and non-coding genetic variants to their target genes across the entire genome simultaneously. This reveals causal biological networks and unlocks the potential for first-in-class blockbuster therapies.


Multi-omics
Our multi-omics framework integrates gene expression, chromatin accessibility, epigenetic regulation, and protein-level activity to reveal how each layer shapes gene function in health and disease. By combining these data modalities within the context of 3D genome architecture, we can pinpoint the regulatory events, pathways, and cellular mechanisms that link genetic variation to biological outcome.
Our Technology
GenLink™ Platform
Our 3D multi-omics platform (GenLink) is the only genome-wide, hypothesis-free technology able to translate massive amounts of disease-associated variant data into causal biology on a cell-type-specific basis.














































Our Technology
GenLink™ Platform
Our 3D multi-omics platform (GenLink) is the only genome-wide, hypothesis-free technology able to translate massive amounts of disease-associated variant data into causal biology on a cell-type-specific basis.














































Our Technology
GenLink™ Platform
Our 3D multi-omics platform (GenLink) is the only genome-wide, hypothesis-free technology able to translate massive amounts of disease-associated variant data into causal biology on a cell-type-specific basis.











































Translating Variant Data Into Function
Our 3D multi-omics platform is the only genome-wide, hypothesis-free technology platform that can translate massive volumes of disease-associated variant data into causal biology on a cell-type-specific basis to illuminate new causal biology and provide opportunities for truly disease-modifying therapies to be developed.

Target Identification
Increasing the number of novel disease targets discovered

Faster Discovery
Reduced timelines compared to conventional approaches

Impactful Therapeutics
New causal biology enables new first-in-class medicines

Cell-type-specific Medicines
Illuminate dysfunction in the precise cells that drive disease

Turning Genetic Insights Into Drug Targets
Our discovery engine translates decades of genetic data into actionable, high-confidence targets by mapping how disease-linked variants disrupt gene function at genome-wide scale.
01
Starting with a sample of (healthy) cells
We begin with carefully selected healthy human cell samples that provide a clean biological baseline.
02
Generating deep multi-omic and 3D genomic data
03
Building the integrated 3D multi-omics atlas
04
Querying GWAS variants against the atlas
05
Triaging and validating high-confidence targets

Turning Genetic Insights Into Drug Targets
Our discovery engine translates decades of genetic data into actionable, high-confidence targets by mapping how disease-linked variants disrupt gene function at genome-wide scale.
01
Starting with a sample of (healthy) cells
We begin with carefully selected healthy human cell samples that provide a clean biological baseline.
02
Generating deep multi-omic and 3D genomic data
03
Building the integrated 3D multi-omics atlas
04
Querying GWAS variants against the atlas
05
Triaging and validating high-confidence targets

Turning Genetic Insights Into Drug Targets
Our discovery engine translates decades of genetic data into actionable, high-confidence targets by mapping how disease-linked variants disrupt gene function at genome-wide scale.
01
Starting with a sample of (healthy) cells
We begin with carefully selected healthy human cell samples that provide a clean biological baseline.
02
Generating deep multi-omic and 3D genomic data
03
Building the integrated 3D multi-omics atlas
04
Querying GWAS variants against the atlas
05
Triaging and validating high-confidence targets
Contact us if you would like to discuss a partnership to enable first-in-class therapies for common diseases.
© 2026 Enhanced Genomics. All rights reserved.
© 2026 Enhanced Genomics. All rights reserved.
© 2026 Enhanced Genomics. All rights reserved.

